The practice of radiation oncology is primarily based on precise technical delivery of highly
conformal, image-guided external beam radiotherapy or brachytherapy. However …

During the last decade, extensive multiplatform genome‐wide analysis has yielded a wealth
of knowledge regarding the genetic and molecular makeup of glioblastoma multiforme …

Background Patients with glioblastoma (GBM) have a dismal prognosis. Nearly all will
relapse with no clear standard of care for recurrent disease (rGBM). Approximately 50% of …

Pediatric high‐grade gliomas (pHGG) comprise a deadly, heterogenous category of
pediatric gliomas with a clear need for more effective treatment options. Advances in high …

The Lazarus effect is a rare condition that happens when someone seemingly dead shows
signs of life. The epidermal growth factor receptor (EGFR) represents a target in the fatal …

Glioblastoma (GB) stands out as the most prevalent and lethal form of brain cancer.
Although great efforts have been made by clinicians and researchers, no significant …

Glioblastoma multiforme is the most malignant and aggressive type of brain tumor, with a
mean life expectancy of less than 15 months. This is due in part to the high resistance to …

Glioblastomas are high-grade brain tumours with a poor prognosis and, currently, few
available therapeutic options. This lack of effective treatments has been linked to diverse …

Glioma is the most common malignant intracranial tumor and exhibits diffuse metastasis and
a high recurrence rate. The invasive property of glioma results from cell detachment. Anoikis …

Glioblastoma (GBM) is the most malignant primary brain tumor. The current standard
approach in GBM is surgery, followed by treatment with radiation and temozolomide (TMZ); …